Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024
Royal Philips has announced its AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology. Results of a new scientific abstract being presented at the American Society of Echocardiography (ASE 2024) annual meeting, June 14-16 in Portland, OR, will demonstrate how first-of-kind AI algorithms co-developed with Philips provide highly accurate detection of regional wall motion abnormalities (RWMA) on echocardiography.
Source: dicardiology.com
